This guide is an educational overview of weight-loss medication in the UK: the main licensed options, how they differ, what the evidence and NICE say, and how a suitable choice is made with a prescriber. It draws on NICE and the UK Summaries of Product Characteristics. It does not rank or promote any medicine; the right option is an individual clinical decision.
Is there a 'best' weight-loss medication?
It is worth saying plainly: there is no single 'best' weight-loss medication that suits everyone 3. These are prescription-only medicines whose suitability depends on your individual circumstances, health, eligibility and tolerance, so the right one is a clinical decision, not a product ranking 23.
This guide therefore does not crown a winner or promote one medicine over another 3. Instead it explains the main licensed options and the factors that determine what is appropriate, which is far more useful than a 'best buy' list for treatments that require a prescription and an assessment 23.
All the licensed options share one feature: they are used alongside a reduced-calorie diet and increased physical activity, as an adjunct rather than a substitute for lifestyle change 123. That common foundation matters whichever medicine is chosen 3.
It is worth being clear about why a 'best buy' framing does not fit medicines like these 2. They are prescription-only treatments, which means they are not advertised or sold to the public the way an ordinary product is, and the choice is made by a prescriber who can assess your suitability rather than by a consumer picking from a ranked list 23. So while it is natural to want a simple answer to 'which is best', the honest and responsible answer is to explain the options and how the decision is made, which is what this guide does 23. A guide that explains the choices serves you better than one that pretends to crown a single winner for everyone 3.
The main licensed options in the UK
The main licensed weight-management medicines in the UK include the newer GLP-1-based injections, namely tirzepatide (Mounjaro), a dual GIP and GLP-1 receptor agonist, and semaglutide (Wegovy), a GLP-1 receptor agonist 12. Both reduce appetite and are given as a weekly injection alongside diet and activity 12.
There is also the older oral medicine orlistat, which works differently, by reducing the amount of fat absorbed from food, rather than acting on appetite 3. It represents a different class and approach from the GLP-1 injections 3.
Each is licensed for defined groups, generally based on BMI and weight-related conditions, and each has its own dosing, side-effect profile and route, which is part of why the right choice is individual 123. Our guide on how to choose a weight-loss treatment goes into the comparison 3.
How the GLP-1 medicines compare
On effectiveness, NICE's appraisal of tirzepatide found, from clinical trial evidence, that it is more effective than diet and exercise support alone, and that indirect comparisons suggest it is more effective than semaglutide alongside diet and exercise support 1. This is presented as NICE's appraisal finding, not as a promotional claim 1.
There are also practical differences. Under NICE guidance, tirzepatide can be used in primary care or specialist weight management services, whereas semaglutide is recommended within a specialist weight management service 12. The escalation schedules, doses and pens also differ 12.
None of this makes one medicine universally 'better' for a given person; effectiveness is only one factor alongside suitability, eligibility, tolerance and access, which a prescriber weighs together 123. Our guide on Mounjaro versus Wegovy compares them in more detail 1.
A higher average effectiveness in trials does not, for example, help someone who cannot tolerate that medicine's side effects, or who does not meet its eligibility criteria, or for whom the access route is not available 12. This is why presenting the NICE finding as information rather than a recommendation matters: it tells you something useful about the medicines in general, but it does not, on its own, tell you which is right for your particular situation, which only an individual assessment can do 23.
Considering treatment for weight management? You can start an assessment with a Cloud Pharmacy clinician, who will review your medical history and confirm whether treatment is appropriate.
Orlistat and the wider picture
Orlistat is a longer-established option that works by reducing fat absorption from the diet rather than by curbing appetite, and it is taken as a capsule with meals 3. Its effect size and side-effect profile differ from the GLP-1 injections, and it may suit some people or situations where an injection is not appropriate or wanted 3.
The existence of more than one approach is part of why a single 'best' label does not fit: an oral fat-absorption medicine and an injectable appetite-reducing medicine are different tools, and which is appropriate depends on the person 3. NICE and the NHS set out the places of these treatments in managing overweight and obesity 3.
Our guide on orlistat covers it in more detail, and our wider treatment guide sets the options side by side 3. The point is breadth of options rather than a ranking 3.
Having a range of approaches is genuinely a strength rather than a complication 3. It means that if one type of medicine is unsuitable, not tolerated, or not accessible for someone, there may be an alternative with a different mechanism and side-effect profile 3. That is a better way to think about choice than ranking everything against a single scale, because the question is not which medicine wins in the abstract but which fits the person in front of the prescriber 23.
How a 'best for you' choice is actually made
The realistic version of 'best' is best for you, which a prescriber determines based on your BMI and weight-related conditions (which affect eligibility), your overall health and other medicines, your tolerance of side effects, and the access route available to you 123. There is no shortcut around that individual assessment 2.
Eligibility is a real gate: NHS access in particular is governed by NICE criteria, which differ between the medicines, so what you can actually get may depend on your BMI, conditions and the rollout, as much as on which medicine performs best in trials 12. Our guides on NICE TA1026 and NHS eligibility cover this 1.
So rather than asking which medicine is best in the abstract, the useful question is which is most appropriate and accessible for your situation, which is exactly what a clinical assessment is for 23. That is why these are prescription-only treatments 2.
How to access weight-loss medication safely
Whichever option is appropriate, the safe route is the same: a proper assessment, a prescription, and supply from a registered pharmacy, whether through the NHS or privately 2. The NHS warns that some websites sell fake weight-loss medicines, so the registered-pharmacy rule protects you 2.
Be wary of anything marketed as a 'best' miracle option, a cheap generic, or a no-prescription purchase, because legitimate weight-loss medicines are prescription-only and supplied after assessment 2. Our guide on avoiding fake pens covers the warning signs 2.
In fact, the language of 'best' and 'miracle' is itself worth treating with suspicion when it comes from a seller, because legitimate, regulated services do not market prescription medicines to the public that way 2. A trustworthy route looks unglamorous by comparison: an assessment, a prescription, a registered pharmacy, and a recognised branded product 2. That lack of hype is a feature, not a drawback, and it is the surest sign you are in the right place 12.
So the overview is this: there is no single best weight-loss medication, the main licensed UK options each have their place, NICE's evidence and your individual circumstances inform the choice, and the safe way to access any of them is through a registered pharmacy after a proper assessment 123.
Frequently asked questions
What is the best weight-loss medication in the UK?
There is no single 'best' option for everyone; the right one depends on your individual circumstances and is a clinical decision rather than a product ranking 23. The main licensed options include tirzepatide (Mounjaro), semaglutide (Wegovy) and the older orlistat, all used alongside diet and activity 123.Is tirzepatide more effective than semaglutide?
NICE's appraisal of tirzepatide found, from clinical trial evidence, that it is more effective than diet and exercise alone, and that indirect comparisons suggest it is more effective than semaglutide alongside diet and exercise 1. This is NICE's finding; effectiveness is only one factor alongside suitability, eligibility and access 12.What weight-loss medications are licensed in the UK?
The main licensed options include the GLP-1-based injections tirzepatide (Mounjaro) and semaglutide (Wegovy), which reduce appetite, and the older oral medicine orlistat, which reduces fat absorption 123. All are used alongside a reduced-calorie diet and increased activity, for defined groups based on BMI and conditions 123.How is the right weight-loss medication chosen for me?
A prescriber weighs your BMI and weight-related conditions (which affect eligibility), your overall health and other medicines, your tolerance of side effects, and the access route available 123. NHS access is governed by NICE criteria that differ between medicines, so what you can get depends on more than trial effectiveness 12.Is orlistat better or worse than Mounjaro or Wegovy?
They are different approaches rather than simply better or worse: orlistat is an oral medicine that reduces fat absorption, while Mounjaro and Wegovy are injections that reduce appetite 31. Which is appropriate depends on the person, their eligibility and preferences, which is why it is an individual clinical decision 3.How do I get weight-loss medication safely in the UK?
Through a proper assessment, a prescription, and a registered pharmacy, whether via the NHS or privately 2. The NHS warns some websites sell fake weight-loss medicines, so be wary of 'miracle' options, cheap generics or no-prescription purchases, which are not how legitimate prescription medicines are supplied 2.Your next step
There is no single 'best' weight-loss medication for everyone; the right option depends on your circumstances and is a clinical decision. The main licensed UK options include the GLP-1 injections tirzepatide (Mounjaro) and semaglutide (Wegovy) and the older oral orlistat, all used alongside diet and activity. NICE found tirzepatide more effective than diet and exercise alone and, by indirect comparison, than semaglutide, but effectiveness is only one factor.
Rather than chasing a 'best' label, the useful question is which option is most appropriate and accessible for you, which a prescriber determines from your BMI, conditions, health, tolerance and access route. Whichever is chosen, get it through a registered pharmacy after a proper assessment, and be wary of 'miracle' options, cheap generics or no-prescription purchases. The breadth of licensed options is a strength, since if one is unsuitable there may be an alternative with a different mechanism that fits you better, which is a far more useful way to think than ranking everything against a single scale and chasing a 'best' that does not exist for everyone. The useful question is always which option is right and accessible for you, which is a question for a prescriber to answer rather than a ranking on a page.
Disclaimer
This guide is for general information only and does not constitute medical advice, diagnosis or treatment. The information here describes general clinical context based on UK regulatory sources cited above; it is not a recommendation for any specific medicine or treatment, which can only be made by a prescriber following individual assessment.
If you are considering treatment, speak to your GP or pharmacist, or arrange a consultation with a Cloud Pharmacy clinician. Prescription-only medicines are issued only after clinical assessment and where appropriate.
If you experience side effects from any medicine, you can report them through the Yellow Card scheme at yellowcard.mhra.gov.uk.
References
- 1 Recommendations / committee discussion (tirzepatide more effective than diet+exercise; indirect comparison more effective than semaglutide; primary care or specialist services)
- 1 Recommendations (semaglutide within a specialist weight management service)
- Overweight and obesity management (adjunct to reduced-calorie diet and physical activity; place of pharmacological options including orlistat)
